Literature DB >> 26203756

Superior Perilimbal Epitheliopathy in Recurrent Corneal Erosion Syndrome.

Kathrin Rac1, Graham A Lee, Stephen J Vincent.   

Abstract

PURPOSE: To highlight the finding of occult areas of poor epithelial adhesion in the superior perilimbal cornea in a minority of patients with recalcitrant recurrent corneal erosion syndrome presenting with corneal erosion elsewhere on the corneal surface. PATIENT POPULATION: Thirty-one eyes of 31 consecutive patients with corneal erosion undergoing mechanical debridement of the epithelium before diamond burr keratectomy for recurrent corneal erosion.
METHODS: Thirty-one eyes of 31 consecutive patients with recurrent corneal erosion were examined for poor epithelial adhesion determined by mechanical debridement with a dry microsponge.
RESULTS: During debridement, 8 of 31 eyes (25.8%) displayed a large arcuate area of occult dysfunction of adhesion in the superior perilimbal area. None of these eyes showed recurrence over a mean of 18 months after diamond burr keratectomy (95% confidence interval, 0%-36.9%).
CONCLUSIONS: Mechanical debridement with a microsponge identified a significant minority of patients with poor adhesion in the superior perilimbal cornea away from the area of obvious erosion and increased the target area for diamond burr keratectomy. This 2-pronged approach allowed successful management of this group.

Entities:  

Mesh:

Year:  2015        PMID: 26203756     DOI: 10.1097/ICO.0000000000000545

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

Review 1.  Superficial Keratectomy: A Review of Literature.

Authors:  Farhad Salari; Alireza Beikmarzehei; George Liu; Mehran Zarei-Ghanavati; Christopher Liu
Journal:  Front Med (Lausanne)       Date:  2022-07-06

2.  Clinical course and risk factors of recurrent corneal erosion: Observational study.

Authors:  Hisataka Nanba; Tatsuya Mimura; Yoshinobu Mizuno; Koichi Matsumoto; Shigeki Hamano; Shoko Ubukata; Megumi Yamamoto; Emiko Watanabe; Atsushi Mizota
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.